Policy Number: | GP 3 | Approve Date: | June 2025 |
Review Frequency: | Triennial | *May be reviewed earlier as required |
1.1. The College of Registered Nurses of Alberta’s (CRNA’s) Council is dedicated to the principles of strong corporate governance, combined with the highest ethical standards in all its activities. The reputation for honesty and integrity is reflected in the way the CRNA conducts its business. The CRNA commits to acting immediately when it receives a disclosure of a concern and expects that all the CRNA community (Council members, Council Committee Members and Employees) share in this commitment.
1.2. The CRNA aims to protect the integrity of its organization, and any individual(s) acting to support that aim, by exposing any suspected wrongdoing within the CRNA through this policy. Due to the involvement of employees in the CRNA’s operations, they are often in the best position to observe and disclose any abuse of trust. In keeping with the CRNA’s commitment to accountability and transparency, this policy provides protection for such “whistleblowers” by enabling safe disclosure and prohibiting reprisals against them.
1.3. The CRNA seeks to support an organizational environment where any individual(s) who observes or has knowledge of a possible abuse of authority and/or violation of policy is empowered to disclose their concerns with this policy. The CRNA encourages members of its community to disclose circumstances that may put the organization at risk for wrongdoing (e.g., lack of appropriate oversight mechanism, absence of checks and balances, etc.)
1.4. This policy protects any individual(s) who submits a disclosure, in good faith, or participates in an investigation, from any retaliation.
2.1. This policy is a control to further safeguard the integrity of the CRNA, utilizing transparent and accessible processes for receiving and acting on any disclosure of suspected wrongdoing.
2.2. This policy encourages and enables individual(s) to disclose concerns within the CRNA, rather than seeking resolution outside the College. Accordingly, the CRNA does not permit retaliation of any kind against any individual for concerns submitted that are made in good faith. It is important that individual(s) feel safe to disclose a concern.3.1. The CRNA will treat all individuals involved in disclosures or investigations fairly, consistently and objectively, regardless of their position or tenure. Disclosures and investigations will be handled with objectivity, confidentiality and sensitivity. Details will be shared only with those who have a legitimate need to know. While every effort will be made to maintain the whistleblower's anonymity and confidentiality, it cannot be guaranteed as other parties might ascertain their identity and/or it may be necessary to disclose identifying information as part of an investigation.
4.1. The CRNA prohibits any consequence or retaliation against any individual(s) who discloses a concern under this policy if they:
• disclose the information in good faith;4.2. The CRNA encourages any individual(s) who witnesses or experiences retaliatory behavior in response to such disclosures to report this behavior as you would report a concern see section 8).
4.3. There may be consequences for disclosures made for reasons beyond what could be considered “good faith,” for example, if the individual is aware that the disclosed information is false or is made with intent to harm another.
5.1. This policy applies to all members of Council, Council Committees and the CEO & Registrar. Any individual in the CRNA Community has the right to disclose a concern and have the protections provided to them through this policy. This policy is not intended to serve as a method for dealing with employee matters that do not involve the CEO, nor as a method for appealing any regulatory decision made by CRNA staff or committees.
Roles and Responsibilities
6.1. Chair of Finance and Audit Committee (FAC Chair) or, as appropriate, an alternate Councillor selected by FAC or Council:
6.2. Finance and Audit Committee (the Committee) or, as appropriate, an alternate Committee as selected by Council:
• Conduct an initial validation of the disclosure received.6.3. Investigation Liaison (appointed by the Committee):
• In collaboration with the third-party service, plans and executes an investigation.6.4. Leadership Review and Governance Committee (LRGC):
• Where there is a finding of wrongdoing by the CEO, recommend to Council and carry out and/or monitor any disciplinary action.6.5. Council:
• Where there is a finding of wrongdoing by a Council or Committee member, carry out and/or monitor any disciplinary action.7.1. Members of the CRNA community have a responsibility to disclose any concerns of suspected wrongdoing. Concerns of suspected wrongdoing may include discrimination, harassment, abuse of authority, bullying, breach of trust, confidentiality, fiduciary duty and/or the integrity of financial reporting or systems.
Online submission form
or by calling: 1-833-834-1029
9.1. Accountability for responding to and acting on a disclosure is outlined in Appendix A.
9.2. The FAC Chair confirms if the disclosure falls within the scope of this policy.
9.3. If the disclosure falls, or it is not clear that it falls, within the scope of this policy, the FAC Chair shall call a meeting of the Committee for the purpose of reviewing a disclosure and determine next steps or actions to be taken. This meeting shall be called:• Immediately, where the subject matter of the disclosure indicates:
- A serious or imminent risk to public health or the organization;
- A high or imminent risk of evidence being lost or destroyed;
- A high or imminent risk of reprisal for the discloser; and/or
- The alleged wrongdoing has not occurred and there is an opportunity to intervene before it does.
Notwithstanding the foregoing, the FAC chair may take interim measure(s), as deemed appropriate, prior to the Committee meeting to address any imminent risk identified above, only to the extent that such interim measure(s) is deemed necessary to address such imminent risk prior to the Committee meeting.
• Within 14 days where the risk to public health, the organization or the disclosure is not imminent.
9.4. At this meeting, the Committee will determine action or next steps to be taken including and not limited to the following:Appendix A
• The CEO & Registrar is responsible for acting on and investigating all disclosures or concerns submitted under the policy where the cited individual(s) is an employee of the CRNA and not the CEO & Registrar. If appropriate, the CEO may escalate a disclosure to the Committee to address the matter to reinforce transparency and objectivity of an investigation. The CEO retains accountability for decision making and remediation or resolution in these matters.
• In the case where the CEO & Registrar, a member of Council, or a member of a Regulatory Committee is cited in the disclosure, the Committee is responsible for overseeing any investigation and making recommendations for remediation. If a disclosure also cites CRNA staff in addition to the CEO and/or a member(s) of Council or a Committee, the Committee may treat the disclosure as a single event. (subject to 11.4 for remediation and/or discipline of a staff member.)
• The Committee is not an appeal body for any regulatory decision. In the event a disclosure is the consequence of regulatory decision, the disclosure shall be forwarded to the CEO & Registrar for actioning by the appropriate individual or committee.